The effectiveness of prostaglandin nanoparticles in corpus luteum regression

Research examined the formation of prostaglandin nanoparticles and their effect on corpus luteum (CL) regression carried out at IRIAP. The nanoparticles formation was carried out using the ionic gelation method. The nanoparticles have a particle size of 316.80±0.14 nm, polydispersion index of 0,453±0,001, zeta potential of +17,40±0,85 mV with 69,69±8.81% hormone entrapment. The effectiveness of nanoparticle in CL regression was observed (prostaglandin vs prostaglandin nanoparticles) using ultrasound observation, hormone profile and estrus response. Further, the size of the ovulating follicle, the time of ovulation, the size of the CL and the onset of estrus after the administration of the prostaglandins were observed. The observation showed that the intramuscular administration of prostaglandin and prostaglandin nanoparticles did not significantly differ on the onset of estrus, time of ovulation, the ovulating follicle size, size of CL and progesterone concentration. The onset of estrus occurred on 2.50 ± 0.58 and 2.33 ± 0.52 days, the ovulation time after hormone administration was on days 3.50 ± 0.55 and 2.83 ± 0.75 with the ovulation follicle size of 16, 62 ± 0.96 and 17.03 ± 1.13 mm, while the CL measures at H-3 were 13.56 ± 2.28 and 10.45 ± 0.88, the progesterone H-2 concentrations were 0.299 and 0.395, respectively for prostaglandin and prostaglandin nanoparticles. It can be concluded that the formation of nanoparticles did not impair the effectiveness of hormones in CL regression so that it can be used to increase the effectiveness of estrus synchronization